MyJournals Home  

RSS FeedsDocetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer--Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial (European Urology)

 
 

21 august 2019 01:00:06

 
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer--Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial (European Urology)
 




In a randomised setting, intermediate- or high-risk prostate cancer patients treated with adjuvant chemotherapy with docetaxel following radical radiotherapy and androgen deprivation therapy (ADT) did not show improved biochemical disease-free survival compared with those who underwent radical radiotherapy and ADT alone. More adverse events occurred with the combined treatment, but there were fewer prostate-specific antigen relapses than were estimated to occur in both groups.


Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
54 viewsCategory: Urology
 
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update (European Urology)
Reply to Gregory J. Nason, Michael A.S. Jewett, and Robert J. Hamilton`s Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.05.031 (European Urology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn